nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—coronary artery disease	0.172	0.392	CbGaD
Minocycline—MMP9—Captopril—coronary artery disease	0.139	0.368	CbGbCtD
Minocycline—IL1B—coronary artery disease	0.11	0.249	CbGaD
Minocycline—VEGFA—coronary artery disease	0.0801	0.182	CbGaD
Minocycline—MMP9—coronary artery disease	0.0775	0.176	CbGaD
Minocycline—SLC22A7—Enalapril—coronary artery disease	0.0335	0.0887	CbGbCtD
Minocycline—SLC22A7—Acetylsalicylic acid—coronary artery disease	0.0254	0.0672	CbGbCtD
Minocycline—SLC22A11—Pravastatin—coronary artery disease	0.0249	0.0659	CbGbCtD
Minocycline—SLC22A7—Pravastatin—coronary artery disease	0.0237	0.0628	CbGbCtD
Minocycline—SLC22A11—Furosemide—coronary artery disease	0.0211	0.056	CbGbCtD
Minocycline—SLC22A8—Enalapril—coronary artery disease	0.0204	0.0542	CbGbCtD
Minocycline—SLC22A8—Pravastatin—coronary artery disease	0.0145	0.0383	CbGbCtD
Minocycline—SLC22A6—Enalapril—coronary artery disease	0.0142	0.0377	CbGbCtD
Minocycline—SLC22A8—Furosemide—coronary artery disease	0.0123	0.0326	CbGbCtD
Minocycline—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0108	0.0286	CbGbCtD
Minocycline—SLC22A6—Captopril—coronary artery disease	0.0107	0.0282	CbGbCtD
Minocycline—SLC22A6—Pravastatin—coronary artery disease	0.0101	0.0267	CbGbCtD
Minocycline—SLC22A6—Furosemide—coronary artery disease	0.00856	0.0227	CbGbCtD
Minocycline—SLC22A6—Losartan—coronary artery disease	0.00839	0.0222	CbGbCtD
Minocycline—MMP9—tunica intima—coronary artery disease	0.00531	0.123	CbGeAlD
Minocycline—CASP3—artery—coronary artery disease	0.00273	0.0634	CbGeAlD
Minocycline—CASP3—endothelium—coronary artery disease	0.00231	0.0535	CbGeAlD
Minocycline—IL1B—artery—coronary artery disease	0.00218	0.0506	CbGeAlD
Minocycline—IL1B—endothelium—coronary artery disease	0.00184	0.0428	CbGeAlD
Minocycline—MMP9—artery—coronary artery disease	0.00182	0.0422	CbGeAlD
Minocycline—CYCS—myocardium—coronary artery disease	0.00168	0.039	CbGeAlD
Minocycline—MMP9—endothelium—coronary artery disease	0.00154	0.0356	CbGeAlD
Minocycline—CASP3—cardiac ventricle—coronary artery disease	0.00153	0.0355	CbGeAlD
Minocycline—CASP3—myocardium—coronary artery disease	0.00144	0.0334	CbGeAlD
Minocycline—CASP1—heart—coronary artery disease	0.00122	0.0283	CbGeAlD
Minocycline—VEGFA—cardiac ventricle—coronary artery disease	0.0012	0.0279	CbGeAlD
Minocycline—CYCS—heart—coronary artery disease	0.00117	0.0272	CbGeAlD
Minocycline—IL1B—myocardium—coronary artery disease	0.00115	0.0267	CbGeAlD
Minocycline—CASP1—cardiovascular system—coronary artery disease	0.00115	0.0267	CbGeAlD
Minocycline—VEGFA—myocardium—coronary artery disease	0.00113	0.0263	CbGeAlD
Minocycline—CYCS—cardiovascular system—coronary artery disease	0.00111	0.0257	CbGeAlD
Minocycline—CASP3—heart—coronary artery disease	0.00101	0.0233	CbGeAlD
Minocycline—Doxycycline—MMP7—coronary artery disease	0.000976	0.392	CrCbGaD
Minocycline—MMP9—myocardium—coronary artery disease	0.000959	0.0223	CbGeAlD
Minocycline—CASP3—cardiovascular system—coronary artery disease	0.000949	0.022	CbGeAlD
Minocycline—CASP1—blood—coronary artery disease	0.00091	0.0211	CbGeAlD
Minocycline—CYCS—blood—coronary artery disease	0.000876	0.0203	CbGeAlD
Minocycline—IL1B—heart—coronary artery disease	0.000803	0.0186	CbGeAlD
Minocycline—VEGFA—heart—coronary artery disease	0.00079	0.0183	CbGeAlD
Minocycline—IL1B—cardiovascular system—coronary artery disease	0.000758	0.0176	CbGeAlD
Minocycline—CASP3—blood—coronary artery disease	0.00075	0.0174	CbGeAlD
Minocycline—Doxycycline—MMP13—coronary artery disease	0.00074	0.297	CrCbGaD
Minocycline—VEGFA—cardiac atrium—coronary artery disease	0.000676	0.0157	CbGeAlD
Minocycline—MMP9—heart—coronary artery disease	0.000669	0.0155	CbGeAlD
Minocycline—MMP9—cardiovascular system—coronary artery disease	0.000632	0.0147	CbGeAlD
Minocycline—IL1B—blood—coronary artery disease	0.000599	0.0139	CbGeAlD
Minocycline—ALOX5—heart—coronary artery disease	0.000529	0.0123	CbGeAlD
Minocycline—Doxycycline—MMP1—coronary artery disease	0.000513	0.206	CrCbGaD
Minocycline—MMP9—blood—coronary artery disease	0.000499	0.0116	CbGeAlD
Minocycline—ALOX5—cardiovascular system—coronary artery disease	0.000499	0.0116	CbGeAlD
Minocycline—VEGFA—Timolol—Penbutolol—coronary artery disease	0.00047	0.145	CbGdCrCtD
Minocycline—CYCS—Rosuvastatin—Pitavastatin—coronary artery disease	0.000406	0.125	CbGdCrCtD
Minocycline—ALOX5—blood—coronary artery disease	0.000395	0.00917	CbGeAlD
Minocycline—CYCS—Captopril—Enalapril—coronary artery disease	0.000274	0.0847	CbGdCrCtD
Minocycline—SLC22A8—blood—coronary artery disease	0.000267	0.0062	CbGeAlD
Minocycline—VEGFA—Enalapril—Captopril—coronary artery disease	0.000219	0.0677	CbGdCrCtD
Minocycline—Methacycline—ALB—coronary artery disease	0.000181	0.0728	CrCbGaD
Minocycline—CYCS—Pimozide—Ezetimibe—coronary artery disease	0.00018	0.0557	CbGdCrCtD
Minocycline—CYCS—Lovastatin—Simvastatin—coronary artery disease	0.000179	0.0551	CbGdCrCtD
Minocycline—CYCS—Lovastatin—Pravastatin—coronary artery disease	0.000179	0.0551	CbGdCrCtD
Minocycline—CYCS—Fluvastatin—Pitavastatin—coronary artery disease	0.000172	0.053	CbGdCrCtD
Minocycline—CYCS—Fluvastatin—Rosuvastatin—coronary artery disease	0.000153	0.0473	CbGdCrCtD
Minocycline—CYCS—Simvastatin—Lovastatin—coronary artery disease	0.000146	0.0452	CbGdCrCtD
Minocycline—CYCS—Simvastatin—Pravastatin—coronary artery disease	0.000146	0.0452	CbGdCrCtD
Minocycline—CYCS—Fluvastatin—Atorvastatin—coronary artery disease	0.00013	0.0402	CbGdCrCtD
Minocycline—CYCS—Pitavastatin—Rosuvastatin—coronary artery disease	0.000125	0.0385	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Perindopril—coronary artery disease	0.000118	0.0366	CbGdCrCtD
Minocycline—CYCS—Pitavastatin—Atorvastatin—coronary artery disease	0.000106	0.0328	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Trandolapril—coronary artery disease	9.24e-05	0.0285	CbGdCrCtD
Minocycline—Tetracycline—ALB—coronary artery disease	7.94e-05	0.0319	CrCbGaD
Minocycline—VEGFA—Enalapril—Lisinopril—coronary artery disease	7.23e-05	0.0223	CbGdCrCtD
Minocycline—VEGFA—Enalapril—Ramipril—coronary artery disease	7.01e-05	0.0216	CbGdCrCtD
Minocycline—MMP9—Signaling Pathways—EDNRA—coronary artery disease	3.51e-06	2.61e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MEF2C—coronary artery disease	3.5e-06	2.61e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RPS6KB1—coronary artery disease	3.5e-06	2.61e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CYBA—coronary artery disease	3.49e-06	2.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB1—coronary artery disease	3.49e-06	2.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—coronary artery disease	3.49e-06	2.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VWF—coronary artery disease	3.49e-06	2.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ATP2A2—coronary artery disease	3.49e-06	2.6e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAT—coronary artery disease	3.48e-06	2.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DUSP6—coronary artery disease	3.48e-06	2.59e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6R—coronary artery disease	3.47e-06	2.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOC3—coronary artery disease	3.47e-06	2.58e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—coronary artery disease	3.45e-06	2.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LDLR—coronary artery disease	3.45e-06	2.57e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—coronary artery disease	3.44e-06	2.56e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLAT—coronary artery disease	3.42e-06	2.55e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ITGB3—coronary artery disease	3.41e-06	2.54e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOB—coronary artery disease	3.38e-06	2.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL3—coronary artery disease	3.37e-06	2.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL2—coronary artery disease	3.37e-06	2.51e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—coronary artery disease	3.34e-06	2.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2R—coronary artery disease	3.33e-06	2.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SDC1—coronary artery disease	3.33e-06	2.48e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PPP2CA—coronary artery disease	3.31e-06	2.47e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—coronary artery disease	3.31e-06	2.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BDKRB2—coronary artery disease	3.3e-06	2.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL12—coronary artery disease	3.3e-06	2.46e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—coronary artery disease	3.29e-06	2.45e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—coronary artery disease	3.29e-06	2.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGB—coronary artery disease	3.26e-06	2.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCD—coronary artery disease	3.25e-06	2.42e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JUNB—coronary artery disease	3.24e-06	2.41e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—coronary artery disease	3.23e-06	2.41e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LPL—coronary artery disease	3.23e-06	2.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—coronary artery disease	3.23e-06	2.4e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLCB1—coronary artery disease	3.22e-06	2.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDNRB—coronary artery disease	3.22e-06	2.4e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK1—coronary artery disease	3.22e-06	2.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—coronary artery disease	3.19e-06	2.37e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—C3—coronary artery disease	3.18e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—THBS1—coronary artery disease	3.17e-06	2.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR7—coronary artery disease	3.16e-06	2.35e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF2—coronary artery disease	3.15e-06	2.35e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX1—coronary artery disease	3.15e-06	2.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSMA6—coronary artery disease	3.14e-06	2.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSMB5—coronary artery disease	3.14e-06	2.34e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CD36—coronary artery disease	3.07e-06	2.28e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—coronary artery disease	3.06e-06	2.28e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.06e-06	2.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDNRA—coronary artery disease	3.04e-06	2.27e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIF1A—coronary artery disease	3.03e-06	2.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CYBA—coronary artery disease	3.03e-06	2.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB1—coronary artery disease	3.03e-06	2.26e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPP2CA—coronary artery disease	3.03e-06	2.26e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGT—coronary artery disease	3.02e-06	2.25e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—JAK2—coronary artery disease	3.02e-06	2.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DUSP6—coronary artery disease	3.02e-06	2.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ITGAV—coronary artery disease	3.01e-06	2.24e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—coronary artery disease	3.01e-06	2.24e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAPK1—coronary artery disease	3e-06	2.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KNG1—coronary artery disease	3e-06	2.23e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—coronary artery disease	2.99e-06	2.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR1—coronary artery disease	2.98e-06	2.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLAT—coronary artery disease	2.97e-06	2.21e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—coronary artery disease	2.96e-06	2.21e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—coronary artery disease	2.96e-06	2.21e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOA1—coronary artery disease	2.93e-06	2.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL10—coronary artery disease	2.91e-06	2.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLG—coronary artery disease	2.91e-06	2.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—coronary artery disease	2.9e-06	2.16e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—coronary artery disease	2.9e-06	2.16e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KDR—coronary artery disease	2.9e-06	2.16e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK14—coronary artery disease	2.88e-06	2.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL12—coronary artery disease	2.86e-06	2.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BDKRB2—coronary artery disease	2.86e-06	2.13e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—coronary artery disease	2.86e-06	2.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—coronary artery disease	2.83e-06	2.11e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—coronary artery disease	2.83e-06	2.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JUNB—coronary artery disease	2.81e-06	2.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—coronary artery disease	2.81e-06	2.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLCB1—coronary artery disease	2.8e-06	2.09e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—coronary artery disease	2.8e-06	2.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCE—coronary artery disease	2.79e-06	2.08e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—coronary artery disease	2.79e-06	2.08e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—coronary artery disease	2.79e-06	2.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SOCS1—coronary artery disease	2.79e-06	2.08e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6ST—coronary artery disease	2.78e-06	2.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—S100B—coronary artery disease	2.78e-06	2.07e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—coronary artery disease	2.76e-06	2.06e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NFKBIA—coronary artery disease	2.76e-06	2.06e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SOCS3—coronary artery disease	2.75e-06	2.05e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR7—coronary artery disease	2.74e-06	2.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR2—coronary artery disease	2.72e-06	2.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KITLG—coronary artery disease	2.72e-06	2.03e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—coronary artery disease	2.7e-06	2.01e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOA1—coronary artery disease	2.67e-06	1.99e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KIT—coronary artery disease	2.67e-06	1.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—coronary artery disease	2.66e-06	1.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT5A—coronary artery disease	2.66e-06	1.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MMP3—coronary artery disease	2.66e-06	1.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ITGAV—coronary artery disease	2.61e-06	1.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—coronary artery disease	2.61e-06	1.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAPK1—coronary artery disease	2.61e-06	1.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KNG1—coronary artery disease	2.6e-06	1.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR1—coronary artery disease	2.59e-06	1.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOB—coronary artery disease	2.57e-06	1.91e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3B—coronary artery disease	2.56e-06	1.91e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.56e-06	1.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MAPK1—coronary artery disease	2.56e-06	1.91e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—coronary artery disease	2.54e-06	1.9e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CREB1—coronary artery disease	2.54e-06	1.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL10—coronary artery disease	2.53e-06	1.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—coronary artery disease	2.53e-06	1.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLG—coronary artery disease	2.52e-06	1.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL5—coronary artery disease	2.51e-06	1.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—coronary artery disease	2.49e-06	1.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—coronary artery disease	2.48e-06	1.85e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6R—coronary artery disease	2.48e-06	1.85e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—coronary artery disease	2.48e-06	1.84e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF1—coronary artery disease	2.47e-06	1.84e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CSF2—coronary artery disease	2.47e-06	1.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—coronary artery disease	2.46e-06	1.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LPL—coronary artery disease	2.45e-06	1.83e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—coronary artery disease	2.45e-06	1.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RPS6KB1—coronary artery disease	2.43e-06	1.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MEF2C—coronary artery disease	2.43e-06	1.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCE—coronary artery disease	2.42e-06	1.81e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	2.42e-06	1.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SOCS1—coronary artery disease	2.42e-06	1.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—S100B—coronary artery disease	2.41e-06	1.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SOCS3—coronary artery disease	2.39e-06	1.78e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ITGB3—coronary artery disease	2.37e-06	1.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KITLG—coronary artery disease	2.36e-06	1.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR2—coronary artery disease	2.36e-06	1.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—coronary artery disease	2.36e-06	1.75e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—coronary artery disease	2.32e-06	1.73e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—coronary artery disease	2.32e-06	1.73e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—coronary artery disease	2.31e-06	1.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP3—coronary artery disease	2.31e-06	1.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT5A—coronary artery disease	2.31e-06	1.72e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PPP2CA—coronary artery disease	2.3e-06	1.71e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—coronary artery disease	2.28e-06	1.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCD—coronary artery disease	2.26e-06	1.68e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF2—coronary artery disease	2.25e-06	1.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOB—coronary artery disease	2.23e-06	1.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—coronary artery disease	2.22e-06	1.65e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—coronary artery disease	2.22e-06	1.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—coronary artery disease	2.21e-06	1.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—coronary artery disease	2.21e-06	1.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—coronary artery disease	2.19e-06	1.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL5—coronary artery disease	2.18e-06	1.62e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JAK2—coronary artery disease	2.16e-06	1.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CSF2—coronary artery disease	2.14e-06	1.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF1—coronary artery disease	2.14e-06	1.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LPL—coronary artery disease	2.13e-06	1.59e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—coronary artery disease	2.13e-06	1.59e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—coronary artery disease	2.12e-06	1.58e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RPS6KB1—coronary artery disease	2.11e-06	1.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MEF2C—coronary artery disease	2.11e-06	1.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIF1A—coronary artery disease	2.11e-06	1.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—coronary artery disease	2.1e-06	1.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ITGB3—coronary artery disease	2.06e-06	1.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—coronary artery disease	2.06e-06	1.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—coronary artery disease	2.06e-06	1.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOA1—coronary artery disease	2.03e-06	1.51e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—coronary artery disease	2.03e-06	1.51e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK1—coronary artery disease	2.01e-06	1.5e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KDR—coronary artery disease	2.01e-06	1.5e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—coronary artery disease	2e-06	1.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK14—coronary artery disease	2e-06	1.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PPP2CA—coronary artery disease	2e-06	1.49e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—coronary artery disease	1.97e-06	1.47e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—coronary artery disease	1.96e-06	1.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCD—coronary artery disease	1.96e-06	1.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—coronary artery disease	1.94e-06	1.44e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—coronary artery disease	1.94e-06	1.44e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6ST—coronary artery disease	1.93e-06	1.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—coronary artery disease	1.92e-06	1.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—coronary artery disease	1.92e-06	1.43e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKBIA—coronary artery disease	1.92e-06	1.43e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KIT—coronary artery disease	1.86e-06	1.38e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—coronary artery disease	1.85e-06	1.38e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—coronary artery disease	1.85e-06	1.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—coronary artery disease	1.85e-06	1.38e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—coronary artery disease	1.83e-06	1.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIF1A—coronary artery disease	1.83e-06	1.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—coronary artery disease	1.82e-06	1.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—coronary artery disease	1.81e-06	1.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—coronary artery disease	1.78e-06	1.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—coronary artery disease	1.78e-06	1.33e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3B—coronary artery disease	1.78e-06	1.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—coronary artery disease	1.78e-06	1.33e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—coronary artery disease	1.77e-06	1.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CREB1—coronary artery disease	1.77e-06	1.32e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOA1—coronary artery disease	1.76e-06	1.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KDR—coronary artery disease	1.75e-06	1.3e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—coronary artery disease	1.75e-06	1.3e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK14—coronary artery disease	1.74e-06	1.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—coronary artery disease	1.73e-06	1.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6R—coronary artery disease	1.72e-06	1.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—coronary artery disease	1.7e-06	1.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—coronary artery disease	1.7e-06	1.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—coronary artery disease	1.68e-06	1.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—coronary artery disease	1.68e-06	1.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6ST—coronary artery disease	1.68e-06	1.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKBIA—coronary artery disease	1.66e-06	1.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—coronary artery disease	1.61e-06	1.2e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KIT—coronary artery disease	1.61e-06	1.2e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—coronary artery disease	1.6e-06	1.19e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF2—coronary artery disease	1.56e-06	1.16e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—coronary artery disease	1.55e-06	1.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3B—coronary artery disease	1.55e-06	1.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—coronary artery disease	1.54e-06	1.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—coronary artery disease	1.53e-06	1.14e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CREB1—coronary artery disease	1.53e-06	1.14e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—coronary artery disease	1.51e-06	1.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—coronary artery disease	1.5e-06	1.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JAK2—coronary artery disease	1.5e-06	1.12e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6R—coronary artery disease	1.5e-06	1.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—coronary artery disease	1.47e-06	1.1e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—coronary artery disease	1.47e-06	1.09e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK1—coronary artery disease	1.44e-06	1.07e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—coronary artery disease	1.43e-06	1.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—coronary artery disease	1.4e-06	1.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—coronary artery disease	1.37e-06	1.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF2—coronary artery disease	1.36e-06	1.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—coronary artery disease	1.34e-06	9.96e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CASP3—coronary artery disease	1.31e-06	9.74e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JAK2—coronary artery disease	1.3e-06	9.68e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—coronary artery disease	1.27e-06	9.48e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—coronary artery disease	1.25e-06	9.3e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—coronary artery disease	1.19e-06	8.84e-06	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—coronary artery disease	1.14e-06	8.49e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CASP3—coronary artery disease	1.13e-06	8.46e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—coronary artery disease	1.11e-06	8.27e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—coronary artery disease	1.11e-06	8.24e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—coronary artery disease	1.1e-06	8.23e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—coronary artery disease	1.07e-06	7.99e-06	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—coronary artery disease	1.02e-06	7.6e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—coronary artery disease	1.02e-06	7.59e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK1—coronary artery disease	9.99e-07	7.44e-06	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—coronary artery disease	9.31e-07	6.94e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—coronary artery disease	8.84e-07	6.59e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK1—coronary artery disease	8.67e-07	6.46e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—coronary artery disease	8.67e-07	6.46e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—coronary artery disease	7.67e-07	5.72e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—coronary artery disease	7.52e-07	5.6e-06	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—coronary artery disease	7.08e-07	5.27e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—coronary artery disease	6.66e-07	4.96e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—coronary artery disease	6.15e-07	4.58e-06	CbGpPWpGaD
